			Home About us Contact

Respiratory Medicine (respiratory + medicine)

Distribution by Scientific Domains

Medical Sciences	100%

Selected Abstracts

Pediatric respiratory medicine,an international perspective

PEDIATRIC PULMONOLOGY, Issue 1 2010
Monika Gappa MD
Abstract Although Pediatric Respiratory Medicine as a subspecialty has a long tradition and is well established in some countries, there is a wide variation across different regions of the world with regard to e.g. recognition of the discipline, training requirements, training facilities and clinical needs. This review summarizes the situation in North America (US and Canada), South America, Asia, Australia, Israel and Europe with the aim to highlight commonalities and differences and, ultimately, to further support continuous development of paediatric Respiratory Medicine Worldwide. Pediatr Pulmonol. 2010; 45:14,24. © 2009 Wiley-Liss, Inc. [source]

Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases

CLINICAL MICROBIOLOGY AND INFECTION, Issue 6 2010
N. Wu
Clin Microbiol Infect 2010; 16: 689,695 Abstract Isolated invasive Aspergillus tracheobronchitis (iIATB) is an uncommon clinical form of invasive Aspergillosis in which Aspergillus infection is limited entirely or predominantly to the tracheobronchial tree. In the present study, we retrospectively analyzed the medical records of 19 patients who had histological documented iIATB in the Department of Respiratory Medicine of Changhai Hospital between October 2000 and February 2008. Malignancy was the most common underlying disease, which existed in 14 patients (73.7%) in our series. Most patients had impaired airway structures or defence functions, whereas the systemic immune status was relatively normal. Only three patients (15.8%) had neutropenia. The clinical manifestations and chest radiograph were nonspecific. We classified iIATB into four different forms according to the bronchoscopic features of intraluminal lesions: superficial infiltration type (Type I, n = 4), full-layer involvement type (Type II, n = 2), occlusion type (Type III, n = 6) and mixed type (Type IV, n = 7). Type IV was the largest group in our study, followed by Type III. All patients with iIATB of Type IV had definite airway occlusion. Fourteen patients (73.7%) had a good response to antifungal treatments and five (26.3%) died as a result of the progression of Aspergillosis, all of whom had full-layer invasion of the involved bronchi. In conclusion, we found that iIATB could occur in moderately or non-immunocompromised patients with impaired airway structures or defence functions and may be an early period of invasive pulmonary Aspergillosis. Most of the iIATB patients had a favourable prognosis with early diagnosis and effective antifungal treatment. The morphological features of intraluminal lesions might be of prognostic value. [source]

Antiphospholipid syndrome: a systemic and multidisciplinary disease

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, Issue 2 2008
L. PAGALAVAN
Abstract Antiphospholipid syndrome (APS) was first described by Hughes and colleagues in 1983. Since the first few initial descriptions of the syndrome, almost every organ in the body has been reported to be involved in APS. The ,Sapporo' criteria which has been used as the diagnostic criteria since 1999 was recently revised in Sydney before the 11th International Congress on antiphospholipid antibodies in 2006. Over the last 24 years it has evolved into a systemic and multidisciplinary disease. This article looks into the extensive multidisciplinary involvement and presentation of APS including neurology, nephrology, cardiology, respiratory medicine, obstetrics and gynecology, endocrinology, hematology, ophthalmology, dermatology, otorhinolaryngology, gastroenterology, and orthopaedics. [source]

Nutritional status and patient characteristics for hospitalised older patients with chronic obstructive pulmonary disease

JOURNAL OF CLINICAL NURSING, Issue 13 2008
Sigrid Odencrants MSc
Aim. The aim of the study was to describe and compare nutritional status and social and medical characteristics among older patients with chronic obstructive pulmonary disease admitted to an acute care hospital ward for respiratory medicine. Background. Chronic obstructive pulmonary disease is a condition associated with risk of developing malnutrition. A body mass index <20 is predictive of hospitalisation for acute exacerbations of chronic obstructive pulmonary disease. Knowledge about patient characteristics is crucial for the identification of malnourished patients and the development of nursing care for these patients. Design. Quantitative descriptive study. Methods. Thirty-three hospitalised women and 17 men with a mean age of 75·7 years (SD 6·9) were consecutively included. A very severe case of chronic obstructive pulmonary disease was indicated in 28 out of 39 patients who underwent a lung function test. Data were collected with measurement of nutritional status using Mini Nutritional Assessment, anthropometry and lung function. Results. Nearly half of the patients (48%) were identified as malnourished, an equal part as at risk for malnutrition and two patients as well nourished. The mean Mini Nutritional Assessment score of 17·2 (SD 3·99) for all patients was near the Mini Nutritional Assessment cut-off score (i.e. 17) for malnutrition. Patients identified as malnourished had a mean body mass index of 18·9 and those at risk for malnutrition had a mean of 23·4. It was more common for those identified as malnourished to live singly, to not live in own property and to be dependent on daily community service. Seven patients identified as malnourished died during the data collection period. Conclusions. This study provides important knowledge about further risks of impaired nutritional status among older patients with chronic obstructive pulmonary disease. Relevance to clinical practice. This knowledge can provide registered nurses with the necessary knowledge to make them aware of certain patients needing particular kinds of attention. [source]

Pediatric respiratory medicine,an international perspective

Prescriber 1990,2010: key developments in drug treatment

PRESCRIBER, Issue 9 2010
FBPharmacolS, Gordon McInnes BSc
Our editorial consultants highlight the significant advances made in their therapeutic areas over the past 20 years. Here we look at developments in CVS and respiratory medicine and diabetes. Copyright © 2010 Wiley Interface Ltd [source]

Evidence-based respiratory medicine: why, where and how

RESPIROLOGY, Issue 4 2002
Dick Ruffin
No abstract is available for this article. [source]

Sleep apnoea , where are the physicians in respiratory medicine?

THE CLINICAL RESPIRATORY JOURNAL, Issue 4 2008
K. A. Franklin
No abstract is available for this article. [source]

Medication-related problems commonly occurring in an Australian community setting,

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Issue 2 2004
E. E. Roughead PhD
Abstract Purpose This study characterised medication-related problems in 1000 Australian patients living in the community, and who were considered at risk of medication misadventure. Methods A review was undertaken of 1000 clinical case notes, developed during the delivery of medication management reviews. Patient demographics, medications used, medical conditions and medication-related problems were categorised according to established classification systems. Descriptive analyses were undertaken. Results Overall, 2222 problems were identified. Ninety per cent of patients had at least one medication-related problem. One in three people were found to require additional monitoring, one in four required additional medication, one in four were using the wrong or inappropriate medication and one in five were using insufficient medication. Cardiovascular, nervous system, alimentary and respiratory medicines were most commonly implicated, accounting for 69% of the medication-related problems. Conclusion This analysis reveals the need for ongoing vigilance of, and support for, people at high risk of medication misadventure. This information is also useful for informing the design of public health or health promotion strategies aiming to reduce the prevalence of these problems. Copyright © 2003 John Wiley & Sons, Ltd. [source]